Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | AR | P10275 | 2/20 | 0.38 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | SCN4A | P35499 | 1/20 | 0.37 |
| ▸ | APP | P05067 | 1/20 | 0.37 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.35 |
| ▸ | METAP2 | P50579 | 1/20 | 0.35 |
| ▸ | PDE2A | O00408 | 2/20 | 0.34 |
| ▸ | TGM2 | P21980 | 1/20 | 0.34 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.33 |
| ▸ | DAO | P14920 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3432404 | 0.83 | CES2 (0.46) | CES2BACE1KDM4EAREPHX2 | |
| SCHEMBL4416163 | 0.81 | CES2 (0.47) | CES2BACE1KDM4EARHCAR1 | |
| SCHEMBL27965595 | 0.80 | CES2 (0.43) | CES2BACE1KDM4EARHCAR1 | |
| SCHEMBL30233883 | 0.79 | CYP1A1 (0.43) | BACE1KDM4EEPHX2SCN4APTPN5 | |
| SCHEMBL1130682 | 0.79 | IDO1 (0.42) | ARHCAR1APP | |
| SCHEMBL25026056 | 0.79 | CYP1A1 (0.43) | BACE1KDM4EEPHX2SCN4APTPN5 | |
| SCHEMBL13523746 | 0.79 | PDE2A (0.46) | BACE1KDM4EEPHX2SCN4APTPN5 | |
| SCHEMBL472401 | 0.79 | CES2 (0.50) | CES2BACE1KDM4EHCAR1EPHX2 | |
| SCHEMBL9996772 | 0.79 | CES2 (0.46) | CES2BACE1KDM4EARHCAR1 | |
| SCHEMBL9996686 | 0.78 | PDE2A (0.49) | BACE1KDM4EEPHX2SCN4APDE2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4420225-A | Lens of a homo- or copolymer of a fluorine containing styrene polymer | BAYER AKTIENGESELLSCHAFT (DE) | 1983-12-13 | — | — | US | claimed |
| EP-0025159-A2 | Use of styrene polymers for the preparation of optical system | BAYER AG (DE) | 1981-03-18 | — | — | EP | claimed |
| CN-109796316-A | Gem-difluoromethyl compound and preparation method thereof | 南京工业大学 | 2019-05-24 | — | — | CN | disclosed |
| EP-2019120-B1 | BLOCK COPOLYMERS | NIPPON SODA CO (JP) | 2016-04-13 | — | — | EP | disclosed |
| US-8895565-B2 | Heterocyclic compound and use of the same | NISHIO TETSUYA (JP) | 2014-11-25 | — | — | US | disclosed |
| US-8193285-B2 | Block copolymers | NIPPON SODA CO., LTD. (JP) | 2012-06-05 | — | — | US | disclosed |
| US-20110319618-A1 | HETEROCYCLIC COMPOUND AND USE OF THE SAME | NISHIO TETSUYA (JP) | 2011-12-29 | — | — | US | disclosed |
| CN-101039935-B | Piperidine antibiotics | ACTELION PHARMACEUTICALS LTD | 2011-04-20 | — | — | CN | disclosed |
| US-20090253867-A1 | BLOCK COPOLYMERS | NIPPON SODA CO., LTD. (JP) | 2009-10-08 | — | — | US | disclosed |
| EP-2019120-A1 | BLOCK COPOLYMERS | Nippon Soda Co., Ltd. (JP) | 2009-01-28 | — | — | EP | disclosed |
| CN-101039935-A | Novel piperidine antibiotics | ACTELION PHARMACEUTICALS LTD (CH) | 2007-09-19 | — | — | CN | disclosed |
| US-5556929-A | FROM UNSATURATED DIESTER WITH URETHANE AND FLUORINE GROUPS AND ACRYLATED SILOXANE, CONTACT LENSES | MENICON CO., LTD. (JP) | 1996-09-17 | — | — | US | disclosed |
| EP-0025159-B1 | USE OF STYRENE POLYMERS FOR THE PREPARATION OF OPTICAL SYSTEM | BAYER AG (DE) | 1984-05-09 | — | — | EP | disclosed |
| US-4420225-A | Lens of a homo- or copolymer of a fluorine containing styrene polymer | BAYER AKTIENGESELLSCHAFT (DE) | 1983-12-13 | — | — | US | disclosed |
| EP-0025159-A2 | Use of styrene polymers for the preparation of optical system | BAYER AG (DE) | 1981-03-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319618-A1 | HETEROCYCLIC COMPOUND AND USE OF THE SAME | CYP2D6, CYP2B6, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | CES2 128/4885BACE1 2324/4885KDM4E 4520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.